prEN 16128

Ophthalmic optics - Reference method for the testing of spectacle frames and sunglasses for nickel release prEN 16128

General information

40.10 harmonizedStageCodeLabel.40.10   Apr 30, 2024

CEN

CEN/TC 170 Ophthalmic optics

European Norm

Scope

Specification of the reference method for the testing of spectacle frames, ready-to-wear near-vision spectacles, sunglasses and spectacle frames used for eye and face protection for nickel release.
The reference method supports the demonstration of conformity with the limit value for nickel release of 0,5 μg·cm-2·week-1 set forth by European Regulation [Regulation (EC) No 1907/2006, REACH, in particular Commission Regulation (EC) No 552/2009 of 22 June 2009 amending regulation (EC) No 1907/2006 of the European Parliament and of the Council on the Registration, Evaluation,
Authorization and restriction of Chemicals (REACH) as regards Annex XVII RESTRICTIONS ON THE MANUFACTURE, PLACING ON THE MARKET AND USE OF CERTAIN DANGEROUS SUBSTANCES, PREPARATIONS AND ARTICLES].
The standard applies to those parts of metal spectacle frames and those metal parts of combination spectacle frames that are intended to come into direct and prolonged contact with the skin of the wearer. It also applies to those relevant metal parts of ready-towear near-vision spectacles, sunglasses and spectacle frames used for eye and face protection.

Related legislation

Legislation related to this standard

1907/2006

Regulation (EC) No 1907/2006 of the European Parliament and of the Council of 18 December 2006 concerning the Registration, Evaluation, Authorisation and Restriction of Chemicals (REACH), establishing a European Chemicals Agency, amending Directive 1999/45/EC and repealing Council Regulation (EEC) No 793/93 and Commission Regulation (EC) No 1488/94 as well as Council Directive 76/769/EEC and Commission Directives 91/155/EEC, 93/67/EEC, 93/105/EC and 2000/21/EC

Life cycle

PREVIOUSLY

PUBLISHED
EN 16128:2015

NOW

IN_DEVELOPMENT
prEN 16128
40.10 harmonizedStageCodeLabel.40.10
Apr 30, 2024